Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
KLHL7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
MEIOC - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MYBL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DSCC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RBM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00888 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
C5orf24 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EP300-AS1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ELMOD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
WRB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DONSON - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NFYB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM20B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
G2E3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
XPNPEP3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PKIA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUDT21 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EIF1AX - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
POGLUT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on